Logo

American Heart Association

  2
  0


Final ID:

Transplant Team: The Biologics

  • Devore, Adam  ( Duke Clinical Research Institute , Chapel Hill , North Carolina , United States )
  • Moazami, Nader  ( NYU , New York , New York , United States )
  • Author Disclosures:
    Adam Devore: DO have relevant financial relationships ; Researcher:Biofourmis, Bodyport, Cytokinetics, American Regent, Inc, the NIH and NHLBI, Natera, Novartis, Story Health, and Ventricle Health:Active (exists now) ; Speaker:Zoll:Past (completed) ; Consultant:NovoNordisk:Active (exists now) ; Other (please indicate in the box next to the company name):Natera (Steering committee):Active (exists now) ; Other (please indicate in the box next to the company name):Myovant (Clinical endpoint committee member):Past (completed) ; Other (please indicate in the box next to the company name):LivaNova (Safety group member):Past (completed) ; Other (please indicate in the box next to the company name):Cardionomic (DSMB):Past (completed) ; Consultant:Bodyport:Past (completed) ; Consultant:Abiomed:Active (exists now) | Nader Moazami: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Advanced Heart Failure Feud: DCD, Recovery, and Xenotransplantation!

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
More abstracts from these authors:
Metabolic and Pharmacokinetic Profiling of Ketone Ester by Background SGLT2 Inhibitor Therapy in Heart Failure with Reduced Ejection: A Phase I Clinical Trial

Selvaraj Senthil, Taylor Lacey, Milosovic Stephanie, Hurdle Melissa, Cade William, Ilkayeva Olga, Muehlbauer Michael, Newgard Christopher, Kelly Daniel, Zamani Payman, Margulies Kenneth, He Caroline, Shah Svati, Thompson Elizabeth, Hornik Christoph, Devore Adam, Patel Chetan, Mentz Robert, Fudim Marat, Kwee Lydia

You have to be authorized to contact abstract author. Please, Login
Not Available